Finasteride Tablet, Film Coated
Product Images NDC 71335-1530

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 71335-1530). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Symptom Score In A Long-term Efficacy And Safety Study (Finasteride Fig1)

The text appears to be a section of a chart or graph displaying the Mean Change from Baseline + 1 SE in Symptom Score in 2 Long Term Efficacy and Safety Study with Placebo and Finasteride over the course of Baseline, Year 1, Year 2, Year 3, and Year 4. Therefore, it is not a useful description, but rather information extracted from a larger document.*

FDA Label Image

Figure 2 Percent Of Patients Having Surgery For Bph, Including Turp (Finasteride Fig2)

FDA Label Image

Figure 3 (Finasteride Fig3)

The text describes a graph (Figure 3) showing the percentage of patients who developed Acute Urinary Retention over a period of time in two groups: those taking Finasteride and those taking a Placebo. The graph shows more patients in the Finasteride group experienced Acute Urinary Retention compared to Placebo. The text also includes data on the number of events and risk per year for each group.*

FDA Label Image

Figure 4 (Finasteride Fig4)

This is a graph showing the mean percent change from the baseline in prostate volume over four years in a long-term study evaluating the efficacy and safety of finasteride compared to a placebo. The study included 155 participants in the placebo group and 157 participants in the finasteride group. The graph shows that the finasteride group had a decrease in prostate volume compared to the placebo group over the four-year study period.*

FDA Label Image

Figure 5 (Finasteride Fig5)

The text describes a graph or figure showing the percentage of individuals experiencing a 4-point increase in AUA Symptom Score over time for different treatment groups. The x-axis indicates the years from randomized treatment while the y-axis shows the percentage with an event (4-point rise in score).*

FDA Label Image

Chemical Structure (Finasteride Str)

FDA Label Image

Label Image (Lbl713351530)

This is a description of a medication called Finasteride 5mg. The medicine is packaged by a company called Bryant Ranch Prepack Burkbank, located in California. The tablet has a blue round shape and should be stored at room temperature, which is between 20°C-25°C (68°F-77°F). This medication is a generic version of Proscar 5mg Tablet, produced by Rising Health LLC. The National Drug Code assigned to this medication is 7133515301 015851001523487.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.